The EASL guidelines on the clinical management of hereditary cholestatic liver disease, published in 2024, suggest that genetic testing should be performed as early as possible in the diagnostic process after ruling out common causes. Along with a better understanding of the genes and proteins involved in biliary homeostasis and the increasing availability of genetic testing, more and more patients with adult-onset cholestasis are being tested for cholestasis genes that play a role in progressive intrahepatic familial cholestasis (PFIC).
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- Lung cancer
Multidisciplinary teams in oncology
- Seborrheic dermatitis in adults
Do not underestimate the symptom burden
- SGLT2 inhibitors
Clear, simple language improves patient safety
- Moderate to severe atopic dermatitis
Established and novel biologics – the therapeutic landscape is in flux
- Recognize CKD early and avoid dialysis
Screen diabetics and hypertensive patients regularly and use modern therapies
- From symptom to diagnosis
Abdominal pain – Inguinal testicles
- Case series